KLOW Blend (GHK-Cu + BPC-157 + TB-500 + KPV)
Also known as: KLOW 80mg Complex (5:1:1:1 Ratio), GHK-Cu 50mg / BPC 10mg / TB500 10mg / KPV 10mg, GLOW + KPV 4-Peptide Blend
Studied in published research — not a medical recommendation. Primary protocol (Standard 80mg KLOW (5:1:1:1) Protocol — 3.0mL BAC Water): 1.75mg GHK-Cu + 350mcg BPC-157 + 350mcg TB-500 + 350mcg KPV (10.5 units on U-100 syringe), Once daily (5 days on / 2 days off, or daily for 28 days).
Once daily (5 days on / 2 days off, or daily for 28 days)
Research-reported range (no primary dosing study). KPV does not cause tanning (unlike Melanotan) and noticeably reduces copper injection-site redness
Subcutaneous injection
Published peer-reviewed research & clinical protocols
No verified human half-life on file for this compound
A vial is powder until you add bacteriostatic water. Change the vial size or water volume below to see the exact unit mark on your syringe.
All U-100: 100 units = 1 mL. 2857 doses in the vial at the low end.
Save KLOW Blend (GHK-Cu + BPC-157 + TB-500 + KPV) to your personal protocol list to log your custom dosage, syringe units, ON/OFF cycle dates, and lab notes across devices.
KLOW Blend (GHK-Cu + BPC-157 + TB-500 + KPV) supplier & $/mg comparison.
At a Glance · 2026 FDA / 503A / WADA / Evidence Profile
Bottom Line Up Front
KLOW is an 80mg 4-peptide lyophilized blend in a 5:1:1:1 ratio: 50mg GHK-Cu + 10mg BPC-157 + 10mg TB-500 + 10mg KPV. Adding KPV (Lys-Pro-Val) to the classic 70mg GLOW formula adds potent MC1R/NF-kB anti-inflammatory signaling for gut barrier integrity, rosacea/eczema calm, and virtually pain-free GHK-Cu injections.
Published preclinical & translational clinical protocols
Large multi-year outcomes in healthy non-clinical cohorts
None
3 (0 human)
EDUCATIONAL AND RESEARCH REFERENCE ONLY — NOT MEDICAL ADVICE. KLOW Blend (GHK-Cu + BPC-157 + TB-500 + KPV) is not FDA approved for human use (unless specified above). This information does not constitute medical advice.
Overview
KLOW Blend is the 80mg four-peptide evolution of the popular GLOW protocol, formulated in a precise 5:1:1:1 ratio (50mg GHK-Cu, 10mg BPC-157, 10mg TB-500, and 10mg KPV). While GHK-Cu drives collagen/elastin gene expression and BPC-157 + TB-500 accelerate microvascular and connective-tissue repair, the addition of 10mg KPV (the C-terminal tripeptide of alpha-MSH) suppresses NF-kB and mast-cell degranulation — soothing both systemic gut/skin inflammation and local copper injection-site irritation.
Mechanisms of Action
- GHK-Cu (50mg) stimulates collagen I/III, elastin, and dermal fibroblast gene expression
- BPC-157 (10mg) & TB-500 (10mg) drive angiogenesis, tendon/dermal matrix repair, and actin mobilization
- KPV (10mg) inhibits NF-kB inflammatory cascades and mast-cell histamine release without melanogenesis (no tanning)
- 4-way synergy supports skin tightening during GLP-1 weight loss alongside gut mucosal repair
Common Ratios, Vial Formats & Dosing Breakdown
Researchers use different ratios depending on whether they reconstitute a pre-mixed vial or draw from separate single-compound vials.
Standard KLOW 80mg Vial (Most Common)
50mg GHK-Cu / 10mg BPC-157 / 10mg TB-500 / 10mg KPV (80mg total)
1.75mg GHK-Cu + 350mcg BPC-157 + 350mcg TB-500 + 350mcg KPV daily (10.5 units w/ 3mL BAC)
Why this ratio: Reconstituted with 3.0 mL BAC water, 10.5 units (0.105 mL) provides a 28-day cycle per vial.
High-Dose KLOW Intensive Protocol
50mg GHK-Cu / 10mg BPC-157 / 10mg TB-500 / 10mg KPV (80mg total)
2.5mg GHK-Cu + 500mcg BPC-157 + 500mcg TB-500 + 500mcg KPV daily (15 units w/ 3mL BAC)
Why this ratio: 20-day intensive skin & soft-tissue remodeling protocol.
Research Protocols
Summaries of published research. For educational purposes only.
| Protocol Name | Source | Dose | Frequency | Duration | Route | Evidence | Link | Save |
|---|---|---|---|---|---|---|---|---|
| Standard 80mg KLOW (5:1:1:1) Protocol — 3.0mL BAC Water | reported protocol | 1.75mg GHK-Cu + 350mcg BPC-157 + 350mcg TB-500 + 350mcg KPV (10.5 units on U-100 syringe) | Once daily (5 days on / 2 days off, or daily for 28 days) | 4–8 weeks, followed by 4-week washout | Subcutaneous injection | animal | — |
Systemic Inflammation, Tissue Repair & Immune Biomarker Panel (KLOW Blend (GHK-Cu + BPC-157 + TB-500 + KPV))
Objective inflammatory, hematologic, and trace-mineral markers to quantify connective-tissue recovery, cytokine resolution, and organ safety.
hs-CRP (High-Sensitivity C-Reactive Protein)
Day 0 + Wk 6–8Why track at baseline: Quantifies baseline systemic IL-6/NF-κB inflammatory burden from tendon, joint, gut, or vascular injury.
Week 6–8 check: Target <1.0 mg/L (optimal <0.5 mg/L) by Week 6–8 as tissue inflammation resolves.
ESR (Sedimentation Rate) & Ferritin
Day 0 + Wk 6–8Why track at baseline: Tracks chronic connective-tissue and autoimmune/mucosal inflammatory activity alongside iron stores.
Week 6–8 check: Downward trend in ESR confirming structural resolution rather than temporary analgesic masking.
CBC with Differential (WBC, Neutrophil/Lymphocyte Ratio)
Day 0 + Wk 6–8Why track at baseline: Evaluates innate/adaptive immune balance (especially for Thymosin Alpha-1, Thymosin Beta-4, LL-37 & KPV).
Week 6–8 check: Balanced lymphocyte count and improved Neutrophil-to-Lymphocyte Ratio (NLR 1.2–2.0).
CMP (Liver/Kidney) + Serum Copper & Zinc Ratio
Day 0 + Wk 6–8Why track at baseline: Verifies baseline hepatic/renal function and checks Copper:Zinc balance before GHK-Cu / GLOW / KLOW protocols.
Week 6–8 check: Maintain 1:1 to 1.2:1 Zinc-to-Copper equilibrium and normal transaminases/creatinine.
Community Outcomes
Community Data Coming Soon
Aggregate community outcomes will be displayed here once we have more reports. Be one of the first to share your experience!
Outcomes are self-reported and unverified. They represent individual experiences and may not reflect typical results.
Important Warnings
- •Contains 50mg GHK-Cu — supplement 2–5mg oral zinc if running 8-week cycles
- •Not evaluated by the FDA; for laboratory research reference only
Where to get KLOW Blend (GHK-Cu + BPC-157 + TB-500 + KPV), baseline labs & clinician oversight.
Ascension Peptides (US Vials)
MZ Biolabs & SafeCert COA-verified US domestic single vials with 50% off auto-applied for new customers.
SwissChems & Limitless Biotech
Same-day US domestic lyophilized vials, oral capsules, and endotoxin-screened nasal sprays (15% off Limitless w/ code PEPTIDEPROTOCOLS).
Superpower Labs & 503A Telehealth
Bloodwork, not a vial store. Get a baseline panel (100+ Quest biomarkers: metabolic, lipids, hormones, inflammation, kidney/liver) before you start a peptide protocol, then retest mid-cycle to see what actually changed.
Where to buy KLOW Blend (GHK-Cu + BPC-157 + TB-500 + KPV): best verified price
Prices checked Nov 11, 2026 · sorted by $/mg · RUO
- 1. Ascension Peptides — $0.75/mg (80mg Lyophilized Vial, $60.00)
- 2. Polaris Peptides — $1.56/mg (80mg KLOW blend 50/10/10/10mg, $125.00)
- 3. Bulletproof BioLabs — $1.63/mg (80mg KLOW blend 80mg, $130.00)
Where is the cheapest place to buy KLOW Blend (GHK-Cu + BPC-157 + TB-500 + KPV)?
As of Nov 11, 2026, the lowest verified US domestic single-vial price we found is Ascension Peptides at $0.75/mg (80mg Lyophilized Vial, $60.00 after the 50% new-customer partner-link discount). We compared 11 US suppliers with live, checked prices.
How much does KLOW Blend (GHK-Cu + BPC-157 + TB-500 + KPV) cost per mg?
Verified US domestic prices currently range from $0.75/mg to $3.44/mg depending on supplier and vial size. Larger vials usually lower the $/mg.
How are these prices verified?
Each price is read from the supplier's own product page or store data and divided by the vial's mg. Suppliers we could not verify are left out rather than estimated. Tables sort strictly by $/mg, never by partner status. Prices are re-checked weekly on our price index.
Is KLOW Blend (GHK-Cu + BPC-157 + TB-500 + KPV) approved for human use?
Products from these suppliers are sold for laboratory research use only (RUO). This page is an educational price reference, not medical advice.
All compounds $/mgWeekly $/mg price indexReconstitution calculatorFree cheat sheet
Peptide Reconstitution & U-100 Syringe Cheat Sheet
Printable U-100 insulin syringe draw chart for 5mg–50mg vials, plus our weekly $/mg price-drop brief.
Vendor vs vendor: price per mg
Head-to-head $/mg on shared compounds. Prices verified Nov 11, 2026.
- Ascension vs SwissChems (3 shared compounds)
- Elite vs SwissChems (3 shared compounds)
- Elite vs Ascension (26 shared compounds)
- Protide vs SwissChems (3 shared compounds)
- Protide vs Ascension (6 shared compounds)
- Ameano vs SwissChems (3 shared compounds)
- Ameano vs Ascension (4 shared compounds)
- Swift vs Ascension (23 shared compounds)
- BioLongevity vs Ascension (16 shared compounds)
- Peptyes vs SwissChems (3 shared compounds)
- Peptyes vs Elite (20 shared compounds)
- Peptyes vs Swift (17 shared compounds)
- Peptyes vs Pure (17 shared compounds)
- Peptyes vs Ascension (20 shared compounds)
Compound vs compound: BPC-157 vs TB-500 · Tirzepatide vs Semaglutide · Retatrutide vs Tirzepatide · Wolverine Blend vs GLOW Blend · Semax vs Selank · KLOW Blend vs GLOW Blend · MOTS-c vs SS-31 · Sermorelin vs Ipamorelin · Retatrutide vs Semaglutide · Tesamorelin vs Sermorelin · All compounds $/mg →
Common questions
How many peptides are in the database?
100 compound pages, each with dosing references, reconstitution math and price per mg where a verified vendor price exists.
Where can I compare peptide prices?
Each compound page shows verified $/mg by vendor; the vendor-vs-vendor pages above compare two vendors across their shared compounds.